Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study
Abstract Background Patients with gout have arterial dysfunction and systemic inflammation, even during intercritical episodes, which may be markers of future adverse cardiovascular outcomes. We conducted a prospective observational study to assess whether initiating guideline-concordant gout therap...
Main Authors: | Michael Toprover, Binita Shah, Cheongeun Oh, Talia F. Igel, Aaron Garza Romero, Virginia C. Pike, Fatmira Curovic, Daisy Bang, Deana Lazaro, Svetlana Krasnokutsky, Stuart D. Katz, Michael H. Pillinger |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-020-02260-6 |
Similar Items
-
Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
by: M S Eliseyev, et al.
Published: (2012-03-01) -
Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
by: M S Eliseyev, et al.
Published: (2012-03-01) -
Uric acid transporter inhibitors for gout
by: Philip K. Tan, et al.
Published: (2017-06-01) -
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
by: Blanka Stiburkova, et al.
Published: (2019-03-01) -
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
by: Rebekah Wrigley, et al.
Published: (2020-03-01)